EPSTEIN-BARR VIRUS INFECTION side effect
What is EPSTEIN-BARR VIRUS INFECTION ?Drugs associated with EPSTEIN-BARR VIRUS INFECTION
ADVIL AZATHIOPRINE BARACLUDE BETASERON BEXTRA CELLCEPT CYCLOPHOSPHAMIDE CYCLOSPORINE CYMBALTA ESCITALOPRAM ETOPOSIDE FLUDARABINE IMATINIB INFLIXIMAB LAMIVUDINE MABCAMPATH MERCAPTOPURINE METHOTREXATE NEVIRAPINE PAXIL PREDNISONE PROGRAF RABBIT REMICADE RITUXIMAB SIMULECT SULFASALAZINE SYMBICORT TACROLIMUS THYMOGLOBULIN VALGANCICLOVIR XYREMEPSTEIN-BARR VIRUS INFECTION : Infliximab Side Effects Report #5654696-7
Physician from UNITED STATES reported INFLIXIMAB problem on Feb 25, 2008. Female patient, 18 years of age, was diagnosed with crohn's disease and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, histiocytosis haematophagic, respiratory distress, therapeutic response decreased, . INFLIXIMAB dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Remicade Side Effects Report #5659550-2
REMICADE problem was reported by a Physician from FRANCE on Feb 29, 2008. Male patient, 21 years of age, was diagnosed with crohn's disease, nutritional support and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . REMICADE dosage: unknown. During the same period patient was treated with NOVATREX, SOLUPRED, SPECIAFOLDINE. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Azathioprine Side Effects Report #5663528-2
Consumer or non-health professional from UNITED KINGDOM reported AZATHIOPRINE problem on Feb 26, 2008. Male patient, 35 years of age, was diagnosed with renal transplant and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, light chain analysis abnormal, lymphoproliferative disorder, skin lesion, skin nodule, . AZATHIOPRINE dosage: 100 MG; DAILY, 100 MG; DAILY. During the same period patient was treated with CYCLOSPORINE, PREDNISOLONE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Mercaptopurine Side Effects Report #5675047-8
MERCAPTOPURINE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2008. Female patient, child 4 years of age, was diagnosed with malignant histiocytosis and was treated with MERCAPTOPURINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . MERCAPTOPURINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, DOXORUBICIN, PREDNISONE, VINBLASTINE SULPHATE, CLADRIBINE, CYTARABINE, METHOTREXATE. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Remicade Side Effects Report #5688243-0
Physician from GERMANY reported REMICADE problem on Mar 20, 2008. Male patient, weighting 220.5 lb, was diagnosed with pyoderma gangrenosum, crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hodgkin's disease, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Remicade Side Effects Report #5688248-X
REMICADE problem was reported by a Physician from GERMANY on Mar 20, 2008. Male patient, weighting 220.5 lb, was diagnosed with pyoderma gangrenosum, crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hodgkin's disease, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Mabcampath Side Effects Report #5688560-4
Pharmacist from NETHERLANDS reported MABCAMPATH problem on Mar 20, 2008. Female patient was diagnosed with t-cell depletion, immunosuppression and was treated with MABCAMPATH. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . MABCAMPATH dosage: unknown. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Azathioprine Side Effects Report #5691968-4
AZATHIOPRINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 12, 2008. Female patient, child 5 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, histiocytosis haematophagic, lymphoproliferative disorder, multi-organ failure, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5613779-8
Health Professional from FRANCE reported METHOTREXATE problem on Feb 04, 2008. Female patient, 62 years of age, was diagnosed with systemic lupus erythematosus and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hepatitis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5614969-0
METHOTREXATE problem was reported by a Health Professional from FRANCE on Feb 05, 2008. Female patient, 62 years of age, was diagnosed with systemic lupus erythematosus and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hepatitis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Remicade Side Effects Report #5619966-7
Physician from FRANCE reported REMICADE problem on Jan 30, 2008. Male patient was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Nevirapine Side Effects Report #5643505-8
NEVIRAPINE problem was reported by a Consumer or non-health professional from on Feb 26, 2008. Female patient, 40 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, smooth muscle cell neoplasm, . NEVIRAPINE dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Valganciclovir Side Effects Report #5580185-4
Physician from UNITED STATES reported VALGANCICLOVIR problem on Nov 26, 2007. Male patient, 33 years of age, weighting 228.0 lb, was treated with VALGANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, neutropenia, . VALGANCICLOVIR dosage: unknown. During the same period patient was treated with PREDNISONE, TACROLIMUS, CELLCEPT, NEUPOGEN. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cymbalta Side Effects Report #5590057-7
CYMBALTA problem was reported by a Physician from UNITED STATES on Jan 03, 2008. Female patient was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hepatitis viral, . CYMBALTA dosage: 60 MG, UNK. During the same period patient was treated with XANAX. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5598645-9
Physician from GERMANY reported METHOTREXATE problem on Jan 08, 2008. Female patient, child 4 years of age, was diagnosed with acute graft versus host disease, prophylaxis against graft versus host disease, stem cell transplant and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, mucosal inflammation, . METHOTREXATE dosage: 5 MG/M2. During the same period patient was treated with ETOPOSIDE, CYCLOSPORINE, STEROIDS. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Remicade Side Effects Report #5604391-5
REMICADE problem was reported by a Physician from GERMANY on Jan 21, 2008. Male patient, weighting 220.5 lb, was diagnosed with pyoderma gangrenosum, crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hodgkin's disease, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cyclosporine Side Effects Report #5537863-2
Consumer or non-health professional from ITALY reported CYCLOSPORINE problem on Nov 27, 2007. Male patient, 26 years of age, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, pneumonia, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with RABBIT ANTITHYMOCYTE GLOBULIN, RABBIT ANTITHYMOCYTE GLOBULIN. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Valganciclovir Side Effects Report #5510189-9
VALGANCICLOVIR problem was reported by a Physician from UNITED STATES on Oct 30, 2007. Male patient, 33 years of age, weighting 228.0 lb, was treated with VALGANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, neutropenia, . VALGANCICLOVIR dosage: unknown. During the same period patient was treated with PREDNISONE, TACROLIMUS, CELLCEPT, NEUPOGEN. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Rituximab Side Effects Report #5523275-4
Physician from GERMANY reported RITUXIMAB problem on Nov 15, 2007. Male patient, 66 years of age, was diagnosed with chronic lymphocytic leukaemia, infection prophylaxis and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . RITUXIMAB dosage: 50 MG/M2, UNK. During the same period patient was treated with FLUDARA, CAMPATH, BENADRYL, ACETAMINOPHEN, COTRIM, BACTRIM. Patient died on 01/01/2007.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5523397-8
METHOTREXATE problem was reported by a Health Professional from FRANCE on Nov 19, 2007. Female patient, 70 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . METHOTREXATE dosage: unknown. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Betaseron Side Effects Report #5524635-8
Consumer or non-health professional from UNITED STATES reported BETASERON problem on Nov 21, 2007. Female patient, 35 years of age, weighting 99.98 lb, was diagnosed with relapsing-remitting multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, feeling abnormal, gait disturbance, heart rate irregular, hypoaesthesia, myocardial infarction, . BETASERON dosage: unknown. During the same period patient was treated with VITAMIN B, VICODIN, GABAPENTIN, VESICARE, AMITRIPTYLINE. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Symbicort Side Effects Report #5477006-7
SYMBICORT problem was reported by a Physician from NETHERLANDS on Sept 27, 2007. Male patient was diagnosed with asthma and was treated with SYMBICORT. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . SYMBICORT dosage: unknown. During the same period patient was treated with BRICANYL, SINGULAIR. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Baraclude Side Effects Report #5479583-9
Health Professional from GERMANY reported BARACLUDE problem on Oct 01, 2007. Female patient, 63 years of age, weighting 132.3 lb, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hepatic cirrhosis, non-hodgkin's lymphoma recurrent, palmar erythema, portal hypertensive gastropathy, . BARACLUDE dosage: unknown. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Prograf Side Effects Report #5493157-5
PROGRAF problem was reported by a Physician from JAPAN on Oct 03, 2007. Male patient was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, evans syndrome, oedema, white blood cell count increased, . PROGRAF dosage: unknown. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cellcept Side Effects Report #5404242-8
Physician from JAPAN reported CELLCEPT problem on July 25, 2007. Male patient, 22 years of age, was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, gastrointestinal haemorrhage, histiocytosis haematophagic, sepsis, small intestine ulcer, . CELLCEPT dosage: unknown. During the same period patient was treated with HORMONE, PROGRAF, SIMULECT. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5391575-7
METHOTREXATE problem was reported by a Consumer or non-health professional from JAPAN on July 02, 2007. Female patient, child 9 years of age, was diagnosed with juvenile arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hodgkin's disease, . METHOTREXATE dosage: 2.5- 12.5 MG (WEEKLY). During the same period patient was treated with PREDNISONE, NAPROXEN. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Prograf Side Effects Report #5391789-6
Physician from JAPAN reported PROGRAF problem on July 05, 2007. Male patient, 18 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, graft versus host disease, meningitis pneumococcal, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE PER ORAL NOS, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISOLONE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Thymoglobulin Side Effects Report #5423749-0
THYMOGLOBULIN problem was reported by a Health Professional from POLAND on June 24, 2004. Female patient, 38 years of age, weighting 127.9 lb, was diagnosed with stem cell transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . THYMOGLOBULIN dosage: 0.5 MG/KG DAILY IV. During the same period patient was treated with TREOSULFAN, FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died on 05/10/2004.
EPSTEIN-BARR VIRUS INFECTION : Rabbit Side Effects Report #5423975-0
Health Professional from ITALY reported RABBIT ATG problem on July 23, 2006. Male patient, 38 years of age, was diagnosed with aplastic anaemia and was treated with RABBIT ATG. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . RABBIT ATG dosage: 3.5 MG/KG QD IV. During the same period patient was treated with HORSE ATG, METHYLPREDNISOLONE, CYCLOSPORINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5391575-7
METHOTREXATE problem was reported by a Consumer or non-health professional from JAPAN on July 02, 2007. Female patient, child 9 years of age, was diagnosed with juvenile arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, hodgkin's disease, . METHOTREXATE dosage: 2.5- 12.5 MG (WEEKLY). During the same period patient was treated with PREDNISONE, NAPROXEN. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Prograf Side Effects Report #5391789-6
Physician from JAPAN reported PROGRAF problem on July 05, 2007. Male patient, 18 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, graft versus host disease, meningitis pneumococcal, . PROGRAF dosage: unknown. During the same period patient was treated with METHOTREXATE PER ORAL NOS, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISOLONE, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Thymoglobulin Side Effects Report #5423749-0
THYMOGLOBULIN problem was reported by a Health Professional from POLAND on June 24, 2004. Female patient, 38 years of age, weighting 127.9 lb, was diagnosed with stem cell transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, lymphoproliferative disorder, . THYMOGLOBULIN dosage: 0.5 MG/KG DAILY IV. During the same period patient was treated with TREOSULFAN, FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died on 05/10/2004.
EPSTEIN-BARR VIRUS INFECTION : Rabbit Side Effects Report #5423975-0
Health Professional from ITALY reported RABBIT ATG problem on July 23, 2006. Male patient, 38 years of age, was diagnosed with aplastic anaemia and was treated with RABBIT ATG. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, . RABBIT ATG dosage: 3.5 MG/KG QD IV. During the same period patient was treated with HORSE ATG, METHYLPREDNISOLONE, CYCLOSPORINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Simulect Side Effects Report #5648474-2
SIMULECT problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Female patient, child 1 years of age, was diagnosed with liver and small intestine transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: cholangitis, epstein-barr virus infection, hepatic steatosis, lymphoproliferative disorder, septic shock, . SIMULECT dosage: unknown. During the same period patient was treated with PROGRAF. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Simulect Side Effects Report #5657978-8
Consumer or non-health professional from JAPAN reported SIMULECT problem on Mar 06, 2008. Female patient, weighting 21.83 lb, was diagnosed with liver and small intestine transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: cholangitis, epstein-barr virus infection, hepatic steatosis, intestinal villi atrophy, lymphoproliferative disorder, mucosal exfoliation, septic shock, . SIMULECT dosage: unknown. During the same period patient was treated with PROGRAF, STEROIDS NOS. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Etoposide Side Effects Report #5676971-2
ETOPOSIDE problem was reported by a Health Professional from UNITED STATES on Mar 17, 2008. Female patient, child 4 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, epstein-barr virus infection, fungal infection, interstitial lung disease, lung infection, lymphadenopathy, pyrexia, sinusitis fungal, splenomegaly, . ETOPOSIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, VINCRISTINE SULPHATE, CLADRIBINE, CYTARABINE, MERCAPTOPURINE, PREDNISONE, VINBLASTINE SULPHATE. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Cyclosporine Side Effects Report #5613591-X
Health Professional from GERMANY reported CYCLOSPORINE problem on Jan 25, 2008. Female patient, child 11 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, epstein-barr virus infection, hepatic failure, immunoblastic lymphoma, lymphadenopathy, mechanical ventilation, multi-organ failure, pyrexia, renal failure, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, METHOTREXATE. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Azathioprine Side Effects Report #5645702-4
AZATHIOPRINE problem was reported by a Consumer or non-health professional from on Feb 25, 2008. Female patient, 51 years of age, was diagnosed with immunosuppression, systemic antiviral treatment and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: complications of transplanted kidney, epstein-barr virus infection, nephropathy toxic, smooth muscle cell neoplasm, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, VALGANCICLOVIR. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Escitalopram Side Effects Report #5584564-0
Consumer or non-health professional from FRANCE reported ESCITALOPRAM problem on Dec 19, 2007. Female patient, 26 years of age, was diagnosed with depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: epidermal necrosis, epstein-barr virus infection, hyperthermia, odynophagia, parvovirus b19 serology positive, toxic skin eruption, . ESCITALOPRAM dosage: 10 MG QD PO. During the same period patient was treated with LAMICTAL, SURMONTIL, IBUPROFEN, SURMONTAL. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cyclophosphamide Side Effects Report #5592636-X
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Jan 09, 2008. Female patient, 67 years of age, was diagnosed with bone marrow conditioning regimen, viral infection and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, epstein-barr virus infection, myelitis, renal failure acute, respiratory failure, septic shock, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE GLOBULIN, GANCICLOVIR, ACYCLOVIR. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Methotrexate Side Effects Report #5598690-3
Physician from GERMANY reported METHOTREXATE problem on Jan 08, 2008. Female patient, child 10 years of age, was diagnosed with prophylaxis against graft versus host disease, bone marrow conditioning regimen and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, epstein-barr virus infection, leukaemia recurrent, mucosal inflammation, pericardial effusion, pulmonary oedema, renal failure, . METHOTREXATE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOSPORINE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Azathioprine Side Effects Report #5603359-2
AZATHIOPRINE problem was reported by a Health Professional from BELGIUM on Jan 14, 2008. Female patient, 51 years of age, was diagnosed with immunosuppression and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: cough, epstein-barr virus infection, haemodialysis, lung neoplasm malignant, metastasis, nephropathy toxic, smooth muscle cell neoplasm, weight decreased, . AZATHIOPRINE dosage: unknown. During the same period patient was treated with CYCLOSPORINE, PREDNISONE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cyclophosphamide Side Effects Report #5537921-2
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Dec 05, 2007. Female patient, 15 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis, aspergillosis and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: aspergillosis, epstein-barr virus infection, lymphoproliferative disorder, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with THIOTEPA, RABBIT ANTITHYMOCYTE GLOBULIN, ORTHOCLONE OKT, HEPARIN, IMMUNE GLOBULIN, METRONIDAZOLE, AMPHOTERICIN B, AMPHOTERICIN B. Patient was hospitalized. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Fludarabine Side Effects Report #5565427-3
FLUDARABINE PHOSPHATE problem was reported by a Consumer or non-health professional from GERMANY on Dec 05, 2007. Female patient, 67 years of age, was diagnosed with multiple myeloma and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus infection, epstein-barr virus infection, myelitis, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ANTITHYMOCYTE IMMUNOGLOBULIN, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Prograf Side Effects Report #5580357-9
Physician from JAPAN reported PROGRAF problem on Dec 14, 2007. Female patient, child 8 years of age, weighting 42.77 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bronchitis, epstein-barr virus infection, leiomyosarcoma, pneumonia pneumococcal, . PROGRAF dosage: 4 MG, BID, ORAL; 2.5 MG, BID, ORAL; 2 MG, BID, ORAL; 1 MG, BID, ORAL; 0.5 MG, BID, ORAL. During the same period patient was treated with CELLCEPT, MEDROL. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Cyclophosphamide Side Effects Report #5504587-7
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from on Oct 25, 2007. Female patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, chronic lymphocytic leukaemia recurrent, infection and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: chronic lymphocytic leukaemia recurrent, epstein-barr virus infection, multi-organ failure, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with PREDNISONE, CHLORAMBUCIL, DOXORUBICIN, VINCRISTINE, FLUDARABINE PHOSPHATE, ANTIBIOTICS. Patient was hospitalized. Patient died.
EPSTEIN-BARR VIRUS INFECTION : Cellcept Side Effects Report #5507564-5
Physician from JAPAN reported CELLCEPT problem on Oct 25, 2007. Male patient, 23 years of age, weighting 112.4 lb, was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: bone marrow disorder, epstein-barr virus infection, gastrointestinal haemorrhage, histiocytosis haematophagic, multi-organ failure, sepsis, small intestine ulcer, . CELLCEPT dosage: unknown. During the same period patient was treated with PROGRAF, SIMULECT, BREDININ. Patient died on 12/26/2003.
EPSTEIN-BARR VIRUS INFECTION : Advil Side Effects Report #5514016-5
ADVIL LIQUI problem was reported by a Health Professional from FRANCE on Nov 07, 2007. Female patient, 19 years of age, was treated with ADVIL LIQUI. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, epstein-barr virus infection, granulocytes maturation arrest, pyrexia, stomatitis, . ADVIL LIQUI dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, PSEUDOEPHEDRINE HYDROCHLORIDE, RHINADVIL, SENNOSIDE A. Patient was hospitalized. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Bextra Side Effects Report #5530859-6
Consumer or non-health professional from UNITED STATES reported BEXTRA problem on Nov 19, 2007. Male patient was diagnosed with headache and was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: body tinea, epstein-barr virus infection, lichen planus, stevens-johnson syndrome, stomatitis, . BEXTRA dosage: unknown. During the same period patient was treated with ERYTHROMYCIN. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Infliximab Side Effects Report #5480378-0
INFLIXIMAB problem was reported by a Health Professional from UNITED KINGDOM on Oct 01, 2007. Male patient, 78 years of age, was diagnosed with rheumatoid arthritis and was treated with INFLIXIMAB. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, epstein-barr virus infection, . INFLIXIMAB dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient recovered.
EPSTEIN-BARR VIRUS INFECTION : Prednisone Side Effects Report #5493750-X
Consumer or non-health professional from reported PREDNISONE problem on Oct 16, 2007. Female patient, 88 years of age, was diagnosed with myasthenia gravis, diffuse large b-cell lymphoma and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: diffuse large b-cell lymphoma, epstein-barr virus infection, . PREDNISONE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, DEXAMETHASONE, RITUXIMAB, PYRIDOSTIGMINE BROMIDE. Patient recovered.